ATLANTA, GA -- (MARKET WIRE) -- October 12, 2006 -- AtheroGenics, Inc. (NASDAQ: AGIX), a pharmaceutical company focused on the treatment of chronic inflammatory diseases, today announced that it expects to release its third quarter 2006 results of operations on Tuesday, October 24, 2006, before the U.S. financial markets open.
